GSK-1292263 ≥98% (by HPLC)
Synonyms:
3-isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
, 3-isopropyl-5-(4-(((6-(4-(methylsulphonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
B1556-5
B1556-25
76270-370EA
758.88
USD
76270-370
76270-368
GSK-1292263 ≥98% (by HPLC)
GSK-1292263
GSK-1292263 is a novel GPR119 receptor agonist and is used for the treatment of type 2 diabetes. GSK1292263 improves glucose regulation in animal models of diabetes, but has no effect on plasma glucose in type 2 diabetics.
Formula:
C₂₃H₂₈N₄O₄S MW: 456,56 g/mol |
MDL Number:
MFCD18385004 CAS Number: 1032823-75-8 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...